Biotechnology Stocks
| # | 過去7日 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2209 |  INBX Inhibrx Biosciences, Inc. - Common Stock | 92.76 USD | -0.64% | -6.59% | -20.97% | +15.12% | 1.37 B USD | ||
| 2211 |  AAPG Ascentage Pharma Group International - American Depository Shar | 14.55 USD | -4.09% | -4.59% | -15.55% | -41.80% | 1.36 B USD | ||
| 2218 |  ANAB AnaptysBio, Inc. - Common Stock | 46.21 USD | +1.23% | -5.64% | -16.87% | +31.28% | 1.34 B USD | ||
| 2244 |  GHRS GH Research PLC - Ordinary Shares | 20.45 USD | -2.90% | -11.28% | -26.36% | +44.42% | 1.27 B USD | ||
| 2253 |  ORIC Oric Pharmaceuticals, Inc. - Common Stock | 12.03 USD | +0.17% | -5.42% | -3.76% | -10.95% | 1.25 B USD | ||
| 2262 |  DRTS Alpha Tau Medical Ltd. - Ordinary Shares | 14.00 USD | -1.75% | -4.96% | +1.45% | +262.69% | 1.23 B USD | ||
| 2265 |  REPL Replimune Group, Inc. - Common Stock | 13.04 USD | -1.21% | -4.75% | -9.88% | +179.83% | 1.23 B USD | ||
| 2277 |  TYRA Tyra Biosciences, Inc. - Common Stock | 19.97 USD | -2.06% | -6.02% | +5.44% | +39.26% | 1.19 B USD | ||
| 2302 |  BCAX Bicara Therapeutics Inc. - Common Stock | 17.26 USD | +5.12% | -5.37% | -26.14% | +19.53% | 1.14 B USD | ||
| 2310 |  VOR Vor Biopharma Inc. - Common Stock | 19.13 USD | +1.86% | +5.75% | -21.82% | +46.03% | 1.13 B USD | ||
| 2311 |  JANX Janux Therapeutics, Inc. - Common Stock | 18.50 USD | +3.24% | +7.25% | -3.50% | -29.31% | 1.13 B USD | ||
| 2321 |  LBRX LB Pharmaceuticals Inc - Common Stock | 34.61 USD | +1.32% | -8.24% | -29.47% | +130.58% | 1.12 B USD | ||
| 2330 |  NBTX Nanobiotix S.A. - ADSs | 22.90 USD | -6.99% | -16.39% | -38.09% | -14.07% | 1.11 B USD | ||
| 2332 |  MNKD MannKind Corporation - Common Stock | 3.42 USD | -0.87% | -14.71% | -17.79% | -35.47% | 1.10 B USD | ||
| 2384 |  MGTX MeiraGTx Holdings plc - Ordinary Shares | 10.50 USD | -2.96% | -2.33% | -21.64% | +20.00% | 1.01 B USD | ||
| 2398 |  CGEM Cullinan Therapeutics, Inc. - Common Stock | 15.46 USD | -1.09% | +4.74% | -26.35% | +117.75% | 994.92 M USD | ||
| 2401 |  SVRA Savara, Inc. - Common Stock | 4.83 USD | -1.02% | -5.29% | -9.55% | +40.82% | 992.37 M USD | ||
| 2404 |  IMTX Immatics N.V. - Ordinary Shares | 7.37 USD | -1.07% | -13.90% | -21.43% | -28.79% | 988.11 M USD | ||
| 2429 |  ANRO Alto Neuroscience, Inc. Common Stock | 24.02 USD | +2.08% | -7.97% | -28.30% | +295.07% | 942.60 M USD | ||
| 2434 |  KURA Kura Oncology, Inc. - Common Stock | 10.52 USD | -1.41% | -2.68% | -12.33% | +2.73% | 935.87 M USD |
ニュース Biotechnology Stocks
RBCキャピタル、Rhythm Pharmaceuticalsの「アウトパフォーム」を維持、目標株価を159ドルに引き上げ
RBCキャピタル、Exelixisの「セクター・パフォーム」を維持、目標株価を45ドルに引き下げ
ADCセラピューティクス、1株1.42ドルで1,290万株、1ワラント1.32ドルで4,810万株を取得できるワラント付きで8,660万ドルのPIPE資金調達を発表；ローンおよびロイヤルティ契約の修正も確保
NutriBand、AVERSA乱用防止経皮技術の保護強化を目的として米国特許出願を提出
BioLineRx社、GLIX1を取り上げた2件の抄録が11月12日～15日に開催される神経腫瘍学会年次総会で発表されることを発表
Atrium Therapeutics、5,170,384株および最大1,134,930株を購入可能なプレファンドワラントの私募を1ユニット約7.93ドルで実施、総額5,000万ドルを発表
「ロシア、シベリアで2件目の感染報告を否定」 - Bloomberg
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |